Study of NK Combined With Chemotherapy for Advanced Solid Tumor

NCT04214730 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

COMBINATION_PRODUCT: NK combined with Chemotherapy
DRUG: Chemotherapy

Sponsor

Yantai Yuhuangding Hospital